Guideline Updates in Nontuberculous Mycobacterial Lung Disease Management

Expert commentary on updates in vaccine development for RSV, from Dr Angela Branche and Clinical Care Options (CCO)

Angela Branche, MD Released: April 7, 2022

Expert commentary on addressing barriers to vaccine uptake in older individuals, from Dr Barbara Resnick and Clinical Care Options (CCO)

Barbara Resnick, PhD, CRNP Released: January 12, 2022

Dr David E. Griffith describes the complex role of in vitro susceptibility testing in the management of NTM lung disease, from Clinical Care Options (CCO)

David E. Griffith, MD Released: December 1, 2021

Dr Princy N. Kumar describes the safety monitoring required of first-line treatment for nontuberculous mycobacterial lung disease, from Clinical Care Options (CCO)

Princy N. Kumar, MD, FIDSA, MACP Released: November 30, 2021